Spark Therapeutics to Participate in Multiple Conferences in February

PHILADELPHIA, Feb. 05, 2018 (GLOBE NEWSWIRE) — Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, today announced that members of company management or investigators will participate in upcoming conferences in February: European Association for Haemophilia and Allied Disorders (EAHAD), at the […] Lire la suite »

Increasing effectiveness in oil industry research on the horizon

BUDAPEST, Hungary, Feb. 05, 2018 (GLOBE NEWSWIRE) — Next to the continuous growth of the renewable energy industry, increasingly greater emphasis is placed on maximizing the effectiveness of extracting fossil fuels and their environmentally friendly processing. ThalesNano’s existing initiatives in this field have just received a major boost via the […] Lire la suite »